stoxline Quote Chart Rank Option Currency Glossary
  
BIOLASE, Inc. (BIOL)
0.1418  -0.008 (-5.09%)    04-12 16:00
Open: 0.149
High: 0.149
Volume: 1,269,186
  
Pre. Close: 0.1494
Low: 0.1407
Market Cap: 5(M)
Technical analysis
2024-04-12 4:47:55 PM
Short term     
Mid term     
Targets 6-month :  0.24 1-year :  0.3
Resists First :  0.21 Second :  0.25
Pivot price 0.16
Supports First :  0.12 Second :  0.1
MAs MA(5) :  0.15 MA(20) :  0.16
MA(100) :  0.65 MA(250) :  5.03
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  8.6 D(3) :  13.8
RSI RSI(14): 34.4
52-week High :  47 Low :  0.12
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ BIOL ] has closed above bottom band by 5.4%. Bollinger Bands are 81.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 27 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.15 - 0.15 0.15 - 0.15
Low: 0.14 - 0.14 0.14 - 0.14
Close: 0.14 - 0.14 0.14 - 0.14
Company Description

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Headline News

Wed, 10 Apr 2024
BIOLASE (NASDAQ:BIOL) Coverage Initiated by Analysts at StockNews.com - Defense World

Tue, 02 Apr 2024
BIOLASE (NASDAQ:BIOL) Receives New Coverage from Analysts at StockNews.com - Defense World

Sat, 23 Mar 2024
BIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call Transcript - Yahoo Finance

Thu, 21 Mar 2024
Biolase: Q4 Earnings Snapshot - Quartz

Thu, 15 Feb 2024
BIOLASE, Inc. Announces Closing of $7.0 Million Public Offering - Yahoo Finance

Thu, 15 Feb 2024
Biolase Raises $7 Million, Expands Capital and Ensures Compliance - TipRanks.com - TipRanks

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 33 (M)
Shares Float 32 (M)
Held by Insiders 0.3 (%)
Held by Institutions 8.2 (%)
Shares Short 289 (K)
Shares Short P.Month 679 (K)
Stock Financials
EPS -29.45
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.08
Profit Margin -42 %
Operating Margin -34.7 %
Return on Assets (ttm) -28.6 %
Return on Equity (ttm) -602.9 %
Qtrly Rev. Growth -4 %
Gross Profit (p.s.) 0
Sales Per Share 1.51
EBITDA (p.s.) -0.43
Qtrly Earnings Growth 0 %
Operating Cash Flow -14 (M)
Levered Free Cash Flow -2 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio -0.1
Price to Book value -2.03
Price to Sales 0.09
Price to Cash Flow -0.33
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android